Concepedia

Hong Jie Soh

HJ

1

Publications

46

Citations

1

H-Index

2021

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Hong Jie Soh is an author at Dana-Farber Cancer Institute specializing in medicine, pharmacology, and tumor biology.

ORCID

Top concepts

Publications per year

2021–2021

1

Publications

1

ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma

Prateek Khanna, Hong Jie Soh, Chun-Hau Chen et al. · Science Translational Medicine · 2021 · 46 citations

, , +16

Rows per page

1–1 of 1